ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. MSFT
9. CRM
10. CRWV

Go back to ASCO 2026: Bayer Shares New Findings for NUBEQA® (darolutamide) Regarding Cognitive Decline in Men with Advanced Prostate Cancer Compared to Enzalutamide in Phase II ARACOG Head-to-Head Trial
Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bay National Corporation (AMEX: BAYN) Delayed: 0.01 --0 (-0%)
Previous Close $0.01    52 Week High $0.04 
Open $61.11    52 Week Low $0.03 
Day High $0.01    P/E 0.00 
Day Low $0.01    EPS $-8.34 
Volume 358,028       

Bayer Aktiengesellschaft American Depositary Shares (AMEX: BAYRY) Delayed: 10.44 +0.04 (0.38%)
Previous Close $10.40    52 Week High $135.54 
Open $10.36    52 Week Low $94.36 
Day High $10.49    P/E N/A 
Day Low $10.30    EPS $0.00 
Volume 614,627       

Bayer AG (AMEX: BAYZF) Delayed: 41.84 +0.48 (1.16%)
Previous Close $41.36    52 Week High $135.00 
Open $41.66    52 Week Low $94.95 
Day High $41.84    P/E N/A 
Day Low $41.66    EPS $0.00 
Volume 3,019